Publication date: Available online 3 November 2016
Source:Auris Nasus Larynx
Author(s): Filippo Carta, Milena Lussu, Fabrizio Bandino, Noto Antonio, Marcello Peppi, Natalia Chuchueva, Atzori Luigi, Vassilios Fanos, Roberto Puxeddu
ObjectiveIdiopathic sudden sensorineural hearing loss is a frequent emergency, with unknown aetiology and usually treated with empiric therapy. Steroids represent the only validated treatment but prognosis is unpredictable and the possibility to select the patients who will not respond to steroids could avoid unnecessary treatments. Metabolomic profiling of the biofluids target the analysis of the final product of genic expression and enzymatic activity, defining the biochemical phenotype of a whole biologic system.MethodsWe studied the metabolomics of the urine of a cohort of patients with idiopathic sudden sensorineural hearing loss, correlating the metabolic profiles with the clinical outcomes. Metabolomic profiling of urine samples was performed by 1H Nuclear Magnetic Resonance spectroscopy in combination with multivariate statistical approaches.Results26 patients were included in the study: 5 healthy controls, 13 patients who did not recover after treatment at 6 months while the remaining 8 patients recovered from the hearing loss. The orthogonal partial least square-discriminant analysis score plot showed a significant separation between the two groups, responders and non-responders after steroid therapy, R2Y of 0.83, Q2 of 0.38 and p value <0.05. The resulting metabolic profiles were characterized by higher levels of urinary B-Alanine, 3-hydroxybutyrate and Trimethylamine N-oxide, and lower levels of Citrate and Creatinine in patients with worst outcome.ConclusionIdiopathic sudden sensorineural hearing loss is a specific disease with unclear systemic changes, but our data suggest that there are different types of this disorder or patients predisposed to effective action of steroids allowing the recover after treatment.
http://ift.tt/2esNDeh
Αρχειοθήκη ιστολογίου
-
►
2023
(256)
- ► Φεβρουαρίου (140)
- ► Ιανουαρίου (116)
-
►
2022
(1695)
- ► Δεκεμβρίου (78)
- ► Σεπτεμβρίου (142)
- ► Φεβρουαρίου (155)
-
►
2021
(5507)
- ► Δεκεμβρίου (139)
- ► Σεπτεμβρίου (333)
- ► Φεβρουαρίου (628)
-
►
2020
(1810)
- ► Δεκεμβρίου (544)
- ► Σεπτεμβρίου (32)
- ► Φεβρουαρίου (28)
-
►
2019
(7684)
- ► Δεκεμβρίου (18)
- ► Σεπτεμβρίου (53)
- ► Φεβρουαρίου (2841)
- ► Ιανουαρίου (2803)
-
►
2018
(31838)
- ► Δεκεμβρίου (2810)
- ► Σεπτεμβρίου (2870)
- ► Φεβρουαρίου (2420)
- ► Ιανουαρίου (2395)
-
►
2017
(31987)
- ► Δεκεμβρίου (2460)
- ► Σεπτεμβρίου (2605)
- ► Φεβρουαρίου (2785)
- ► Ιανουαρίου (2830)
-
▼
2016
(5308)
- ► Δεκεμβρίου (2118)
-
▼
Νοεμβρίου
(1322)
-
▼
Νοε 03
(50)
- Metabolomic analysis of urine with Nuclear Magneti...
- Contents
- Forthcoming Issues
- Surgical Critical Care for the Trauma Patient with...
- Anesthesia for Patients with Peripheral Vascular D...
- Copyright
- Efficacy and mechanism of mandibular advancement d...
- Evaluating the efficacy of voice therapy for funct...
- Ein Jahr Epistaxisbehandlung in den Notfallambulan...
- Management of surgical difficulties during cochlea...
- Soft-wall reconstruction of the canal wall with re...
- Diagnostic hearing testing of infants aged 0–36 mo...
- Polymorphisms of Cytokine Genes and Polycystic Ova...
- The functional role of the pharyngeal plexus in vo...
- Prophylactic exercises among head and neck cancer ...
- Terapia omalizumabem u pacjentki z ciężką eozynofi...
- Astma prurigo
- Radykalna poprawa kontroli astmy oskrzelowej po wł...
- Skuteczne leczenia omalizumabem chorej na ciężką a...
- Pokrzywka przewlekła u chorej na ciężką astmę atop...
- Korzyści z leczenia omalizumabem wykraczające poza...
- Pacjentka z ciężką astmą wyłączona z leczenia omal...
- Metabolomic analysis of urine with Nuclear Magneti...
- Clinical benefit of component-resolved diagnosis i...
- Efficacy and mechanism of mandibular advancement d...
- Springtime Birth as a Melanoma Risk: Is It Real?
- Two Ipilimumab Trials Show Survival Benefit, and M...
- Phase II Trial of Pembrolizumab With Trastuzumab a...
- Trial of Hu5F9-G4 in Combination With Cetuximab in...
- Seventy-six-year-old woman with an unusual anatomy...
- Surgical Removal of an Extrauterine Device Migrati...
- The BANK1 SLE-risk variants are associated with al...
- Long-term low-dose macrolides for Chronic Rhinosin...
- Fibro-odontome améloblastique mandibulaire chez un...
- Glimpses of the near future: A new generation of m...
- HMGA2 is associated with the aggressiveness of ton...
- Can topical beta-blockers reduce the size of super...
- Characterizing mortality in pediatric tracheostomy...
- A new solution for neonatal bilateral vocal cord p...
- Subsite variation in survival of oropharyngeal squ...
- An open-label study of sodium oxybate in Spasmodic...
- A rare association between constrictive pericardit...
- Editorial
- Masthead - Editorial Board And Table of Contents
- Transepidermal water loss in infancy associated wi...
- New and recurrent STAT1 mutations in seven Chinese...
- Nail involvement associated with palmoplantar pust...
- ADF Winter School—An exciting concept of the Arbei...
- Increased airway hyperresponsiveness to adenosine ...
- Just a Cut
-
▼
Νοε 03
(50)
- ► Σεπτεμβρίου (877)
- ► Φεβρουαρίου (41)
- ► Ιανουαρίου (39)
Αλέξανδρος Γ. Σφακιανάκης
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5
Άγιος Νικόλαος Κρήτη 72100
2841026182
6032607174
Πέμπτη 3 Νοεμβρίου 2016
Metabolomic analysis of urine with Nuclear Magnetic Resonance spectroscopy in patients with idiopathic sudden sensorineural hearing loss: A preliminary study
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου